Merck
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
CEORobert M. Davis
CEORobert M. Davis
Employees75,000
Employees75,000
HeadquartersRahway, New Jersey
HeadquartersRahway, New Jersey
Founded1891
Founded1891
Employees75,000
Employees75,000
MRK Key Statistics
Market cap196.20B
Market cap196.20B
Price-Earnings ratio11.58
Price-Earnings ratio11.58
Dividend yield4.05%
Dividend yield4.05%
Average volume19.85M
Average volume19.85M
High today$78.75
High today$78.75
Low today$76.21
Low today$76.21
Open price$76.89
Open price$76.89
Volume21.42M
Volume21.42M
52 Week high$134.63
52 Week high$134.63
52 Week low$75.93
52 Week low$75.93
MRK News
Simply Wall St 2d
Merck Secures Global Rights To Cyprumed's Oral Peptide Delivery TechnologyLast week, entered into a non-exclusive license and option agreement with Cyprumed GmbH, aiming to enhance its peptide offerings through innovative oral deliver...
Benzinga 3d
Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet-Based Peptide DeliveryMerck & Co Inc MRK and privately held Cyprumed GmbH signed a non-exclusive license and option agreement on Tuesday to develop oral formulations of Merck's pepti...
Analyst ratings
65%
of 26 ratingsBuy
65.4%
Hold
34.6%
Sell
0%